tiprankstipranks
Advertisement
Advertisement

OLMA Stock Latest News

Olema Highlights Encouraging OP-3136 Phase 1 Oncology Results
Company AnnouncementsOlema Highlights Encouraging OP-3136 Phase 1 Oncology Results
2h ago
8K
OLMA
Citi opens ‘upside 90-day catalyst watch’ on Olema Oncology
PremiumThe Fly
Citi opens ‘upside 90-day catalyst watch’ on Olema Oncology
8d ago
OLMA
Olema Pharmaceuticals: Citi’s Anupam Rama Reiterates Buy on Underappreciated Palazestrant Upside and Long-Term Pipeline Catalysts
PremiumRatings
Olema Pharmaceuticals: Citi’s Anupam Rama Reiterates Buy on Underappreciated Palazestrant Upside and Long-Term Pipeline Catalysts
9d ago
OLMA
Olema Oncology price target lowered to $35 from $38 at Guggenheim
PremiumThe Fly
Olema Oncology price target lowered to $35 from $38 at Guggenheim
9d ago
PFE
OLMA
Olema Pharmaceuticals: Differentiated KAT6i and Palazestrant Pipeline Catalysts Underpin Buy Rating
PremiumRatings
Olema Pharmaceuticals: Differentiated KAT6i and Palazestrant Pipeline Catalysts Underpin Buy Rating
9d ago
OLMA
Olema Oncology reports Q1 EPS (52c), consensus (54c)
PremiumThe FlyOlema Oncology reports Q1 EPS (52c), consensus (54c)
10d ago
OLMA
Olema Pharmaceuticals Signs New Headquarters Lease at Oyster Point
Premium
Company Announcements
Olema Pharmaceuticals Signs New Headquarters Lease at Oyster Point
20d ago
8K
OLMA
Olema Pharmaceuticals Adds Veteran Director to Support Growth
Premium
Company Announcements
Olema Pharmaceuticals Adds Veteran Director to Support Growth
22d ago
8K
OLMA
Olema Oncology to present initial clinical data for OP-3136 at ASCO
PremiumThe Fly
Olema Oncology to present initial clinical data for OP-3136 at ASCO
1M ago
OLMA
Olema Oncology announces preclinical data for Palazestrant
PremiumThe Fly
Olema Oncology announces preclinical data for Palazestrant
1M ago
OLMA
Olema Oncology initiated with a Peer Perform at Wolfe Research
PremiumThe Fly
Olema Oncology initiated with a Peer Perform at Wolfe Research
2M ago
OLMA
Olema Oncology assumed with a Buy at Jefferies
PremiumThe Fly
Olema Oncology assumed with a Buy at Jefferies
2M ago
OLMA
Olema Oncology price target raised to $58 from $55 at JPMorgan
PremiumThe FlyOlema Oncology price target raised to $58 from $55 at JPMorgan
2M ago
OLMA
Olema Oncology price target lowered to $27 from $38 at Goldman Sachs
Premium
The Fly
Olema Oncology price target lowered to $27 from $38 at Goldman Sachs
2M ago
OLMA
Olema Oncology price target lowered to $38 from $40 at Guggenheim
Premium
The Fly
Olema Oncology price target lowered to $38 from $40 at Guggenheim
2M ago
AZN
CHRO
Olema Oncology price target raised to $62 from $60 at Citi
PremiumThe Fly
Olema Oncology price target raised to $62 from $60 at Citi
2M ago
OLMA
Olema Pharmaceuticals: Palazestrant Phase III Upside and Differentiated Pipeline Underpin Buy Rating
PremiumRatings
Olema Pharmaceuticals: Palazestrant Phase III Upside and Differentiated Pipeline Underpin Buy Rating
2M ago
OLMA
Buy Rating Reaffirmed on Palazestrant’s Differentiated Phase 3 Program and Favorable Risk‑Reward Profile for Olema
PremiumRatings
Buy Rating Reaffirmed on Palazestrant’s Differentiated Phase 3 Program and Favorable Risk‑Reward Profile for Olema
2M ago
OLMA
Olema Oncology reports Q4 EPS (50c), consensus (53c)
PremiumThe Fly
Olema Oncology reports Q4 EPS (50c), consensus (53c)
2M ago
OLMA
Maintaining a Buy on Olema: Differentiated Palazestrant Profile Supports Upside Despite Negative Giredestrant Read-Through
PremiumRatingsMaintaining a Buy on Olema: Differentiated Palazestrant Profile Supports Upside Despite Negative Giredestrant Read-Through
2M ago
OLMA
Constructive Read‑Through From Giredestrant Data Supports Olema’s Palazestrant and Underpins Buy Rating Despite Sector Setbacks
Premium
Ratings
Constructive Read‑Through From Giredestrant Data Supports Olema’s Palazestrant and Underpins Buy Rating Despite Sector Setbacks
2M ago
OLMA
H.C. Wainwright does not see direct read from Roche miss to Olema’s OPERA-02
Premium
The Fly
H.C. Wainwright does not see direct read from Roche miss to Olema’s OPERA-02
2M ago
CHRO
OLMA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >